MEB enters fully funded Paediatric mental illness diagnostic
Filed with ASX · · 3 pages · English
Earlier from TrivarX
- Conversion of Options to Partly Paid shares
- MEB appoints US med-tech veteran as CEO & Managing Director
- Early Redemption of Convertible Note
- Partnership with leading US University on PTSD
- Excellent performance in the pilot phase of US Validation
Later from TrivarX
- Quarterly ASX Update and Cashflow
- MEB Signs Strategic Joint Development Agreement with Mayo Cl
- Signed second agreement for Wellness
- Independent researchers present first data validating MEB
- Scientific breakthrough on objective diagnosis of PTSD
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX